Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gullestad

Showing results (361-370 of 382) with videos related to

Pageof 39
Sort By:
Journal of the American College of Cardiology|November 3, 2018
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin TMichele Emdin, Alberto Aimo, Giuseppe Vergaro, et al.
Ebiomedicine|July 30, 2021
Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trialAyodeji Awoyemi, Cristiane Mayerhofer, Alex S Felix, et al.
Ebiomedicine|September 14, 2020
Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosisNathalie Niyonzima, Siril S Bakke, Ida Gregersen, et al.
Journal of the American College of Cardiology|April 16, 2021
Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial InfarctionKaspar Broch, Anne Kristine Anstensrud, Sindre Woxholt, et al.
The Journal of Physiology|April 30, 2024
Regulation of cardiomyocyte t-tubule structure by preload and afterload: Roles in cardiac compensation and decompensationMarianne Ruud, Michael Frisk, Arne Olav Melleby, et al.
JACC. Advances|September 9, 2024
Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated With Infarct SizeKristine Mørk Kindberg, Kaspar Broch, Geir Øystein Andersen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 16, 2022
Blood Milieu in Acute Myocardial Infarction Reprograms Human Macrophages for Trauma RepairMargaux A C Fontaine, Han Jin, Mick Gagliardi, et al.
European Journal of Heart Failure|January 27, 2009
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of CardiologyStephane Heymans, Emilio Hirsch, Stefan D Anker, et al.
The New England Journal of Medicine|November 7, 2007
Rosuvastatin in older patients with systolic heart failureJohn Kjekshus, Eduard Apetrei, Vivencio Barrios, et al.
Journal of Molecular and Cellular Cardiology|May 13, 2014
CXCR4 blockade induces atherosclerosis by affecting neutrophil functionIlze Bot, Isabelle T M N Daissormont, Alma Zernecke, et al.
Pageof 39

Showing results (361-370 of 382) with videos related to

Sort By:
Pageof 39
Journal of the American College of Cardiology|November 3, 2018
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin TMichele Emdin, Alberto Aimo, Giuseppe Vergaro, et al.
Ebiomedicine|July 30, 2021
Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trialAyodeji Awoyemi, Cristiane Mayerhofer, Alex S Felix, et al.
Ebiomedicine|September 14, 2020
Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosisNathalie Niyonzima, Siril S Bakke, Ida Gregersen, et al.
Journal of the American College of Cardiology|April 16, 2021
Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial InfarctionKaspar Broch, Anne Kristine Anstensrud, Sindre Woxholt, et al.
The Journal of Physiology|April 30, 2024
Regulation of cardiomyocyte t-tubule structure by preload and afterload: Roles in cardiac compensation and decompensationMarianne Ruud, Michael Frisk, Arne Olav Melleby, et al.
JACC. Advances|September 9, 2024
Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated With Infarct SizeKristine Mørk Kindberg, Kaspar Broch, Geir Øystein Andersen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 16, 2022
Blood Milieu in Acute Myocardial Infarction Reprograms Human Macrophages for Trauma RepairMargaux A C Fontaine, Han Jin, Mick Gagliardi, et al.
European Journal of Heart Failure|January 27, 2009
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of CardiologyStephane Heymans, Emilio Hirsch, Stefan D Anker, et al.
The New England Journal of Medicine|November 7, 2007
Rosuvastatin in older patients with systolic heart failureJohn Kjekshus, Eduard Apetrei, Vivencio Barrios, et al.
Journal of Molecular and Cellular Cardiology|May 13, 2014
CXCR4 blockade induces atherosclerosis by affecting neutrophil functionIlze Bot, Isabelle T M N Daissormont, Alma Zernecke, et al.
Pageof 39